Filter by tags: Metastasis Russia Clear all tag filters
3 news articles found
Russia’s AI Leipunsky Institute of Physics & Power Engineering (IPPE) together with V/O Izotop JSC (part of Rusatom Healthcare), have optimised the production process for actinium-225 (Ac-225). Targeted therapy using radiopharmaceuticals based on the radioisotope Ac-225 is proving effective in the treatment of inoperable metastatic cancer. IPPE is one of the three producers of Ac-225 in the world and the only one in Russia.
- Source: NEI Magazine
- Date: Saturday, 18 March 2023
- Original article: neimagazine.com/news/newsrussias-ippe-improves-production-process-for-actinium-225-10682579
Rosatom has begun construction of a new plant for the production of medical isotope products at the Karpov Scientific Research Institute of Physics & Chemistry in Obninsk, Kaluga region. The plant will produce a wide range of radiopharmaceuticals including those based on iodine-131, samarium-153, and molybdenum-99 isotopes. It will also develop promising active radiopharmaceuticals based on lutetium-177, actinium-225, radium-223 and other isotopes. Once completed, in 2025, it will be the largest such facility in Europe, Rosatom says. It will operate in accordance with international GMP (good manufacturing practice) standards.
- Source: NEI Magazine
- Date: Friday, 27 January 2023
- Original article: neimagazine.com/news/newsrosatom-begins-construction-of-radiopharmaceuticals-plant-10546229
Three recent announcements will help secure future supplies of vital medical radioisotopes. Westinghouse Electric Company and Nordion (Canada) Inc are to work together on technology to produce cobalt-60 in pressurised water reactors (PWRs); Framatome and Kinectrics have launched a new joint venture to produce lutetium-177 in partnership with Bruce Power; and BWXT Technologies' proprietary technetium-99m generators have passed a testing milestone.
- Source: World Nuclear News
- Date: Saturday, 29 February 2020
- Original article: world-nuclear-news.org/Articles/Companies-work-on-securing-medical-isotope-supplie